LPCN Posts $14.9M Cash, $9.6M Net Loss; Advances LPCN 1154 PPD Phase 3, LPCN 2201 MDD, LPCN 2101 Epilepsy, LPCN 2401 Obesity, TLANDO Partnerships
Lipocine Inc. · PHARMACEUTICAL PREPARATIONS · Now $2.28
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS